Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Glover

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 16, 2023
The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid CancerMatti L Gild, Shejil Kumar, Talia L Fuchs, et al.
Cancer|December 5, 2013
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancerJames C Lee, Jing Ting Zhao, Roderick J Clifton-Bligh, et al.
Annals of Surgical Oncology|July 19, 2021
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
Asia-Pacific Journal of Clinical Oncology|August 15, 2024
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocolAnna K Lawless, Shejil Kumar, Jessica Bindra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
Endocrinology and Metabolism (Seoul, Korea)|February 17, 2025
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)Jae Hoon Moon, Eun Kyung Lee, Wonjae Cha, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 16, 2023
The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid CancerMatti L Gild, Shejil Kumar, Talia L Fuchs, et al.
Cancer|December 5, 2013
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancerJames C Lee, Jing Ting Zhao, Roderick J Clifton-Bligh, et al.
Annals of Surgical Oncology|July 19, 2021
Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
Asia-Pacific Journal of Clinical Oncology|August 15, 2024
Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocolAnna K Lawless, Shejil Kumar, Jessica Bindra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
Endocrinology and Metabolism (Seoul, Korea)|February 17, 2025
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)Jae Hoon Moon, Eun Kyung Lee, Wonjae Cha, et al.
Pageof 6